(Circulation. 1995;92:428-432.)
© 1995 American Heart Association, Inc.
Articles |
From the Departments of Surgery (M.C.O., Y.N., A.S., R.E.M., C.R.S., E.A.R.), Physiology (H.L., D.N.B., D.M.S.), and Medicine (D.J.P.), College of Physicians and Surgeons, Columbia University, New York, NY.
Correspondence to Mehmet C. Oz, MD, Columbia University, College of Physicians and Surgeons, Milstein 7-435, 177 Fort Washington Ave, New York, NY 10032. E-mail mco2@columbia.edu.
Background Interleukin-8 (IL-8) secreted from endothelial cells is a powerful neutrophil chemoattractant and activator. We hypothesized that human endothelial cells deprived of oxygen would secrete IL-8, which might translate into elevated IL-8 production after cardiac ischemia. Furthermore, we hypothesized that coronary sinus (CS) IL-8 levels would be particularly high after cardiac preservation for transplantation, due to extended ischemic times.
Methods and Results Human saphenous vein endothelial cells exposed to a hypoxic environment (PO2 <20 mm Hg) demonstrated a time-dependent release of IL-8 (measured by ELISA) into the culture supernatant as early as 4 hours after exposure. To determine whether cardiac preservation in humans was associated with IL-8 production, we obtained CS blood samples 5 minutes after reperfusion in a consecutive series of patients after they underwent cardiac transplantation (CTX, n=20) or elective cardiac surgery (non-CTX, n=21). CTX patients demonstrated significantly higher CS IL-8 levels than non-CTX patients (325±123 versus 50±17 ng/mL, respectively, P<.05). Further analysis of the CS samples revealed that a biochemical marker of myocyte injury (myoglobin) was similarly elevated in the CTX patients compared with the non-CTX patients (3340±625 versus 1151±525 ng/mL, respectively, P<.05).
Conclusions These differences may reflect the longer ischemic times of CTX compared with non-CTX hearts (161±10 versus 80±6 minutes, P<.0001) and suggest that the neutrophil chemoattractant/activator IL-8 may contribute to myocyte injury after prolonged hypothermic cardiac ischemia, as occurs during human cardiac transplantation.
Key Words: transplantation ischemia endothelium interleukins
This article has been cited by other articles:
![]() |
M. DE PERROT, Y. SEKINE, S. FISCHER, T. K. WADDELL, K. MCRAE, M. LIU, D. A. WIGLE, and S. KESHAVJEE Interleukin-8 Release during Early Reperfusion Predicts Graft Function in Human Lung Transplantation Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 211 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lango, L. Anisimowicz, J. Siebert, J. Rogowski, A. Bakowska, P. Mrozinski, and M. Narkiewicz IL-8 concentration in coronary sinus blood during early coronary reperfusion after ischemic arrest Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 550 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Arnould, R. Thibaut-Vercruyssen, N. Bouaziz, M. Dieu, J. Remacle, and C. Michiels PGF2{{alpha}}, a Prostanoid Released by Endothelial Cells Activated by Hypoxia, Is a Chemoattractant Candidate for Neutrophil Recruitment Am. J. Pathol., July 1, 2001; 159(1): 345 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kharbanda, M. Peters, B. Walton, M. Kattenhorn, M. Mullen, N. Klein, P. Vallance, J. Deanfield, and R. MacAllister Ischemic Preconditioning Prevents Endothelial Injury and Systemic Neutrophil Activation During Ischemia-Reperfusion in Humans In Vivo Circulation, March 27, 2001; 103(12): 1624 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wan, J.-L. LeClerc, and J.-L. Vincent Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned From Cardiac Transplantation Ann. Thorac. Surg., January 1, 1997; 63(1): 269 - 276. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |